Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Nature Cell Biology|August 21, 2007
The F-box protein Fbl10 is a novel transcriptional repressor of c-JunRyo Koyama-Nasu, Gregory David, Naoko TaneseInternational Journal of Molecular Sciences|July 12, 2017
miRNAs in Normal and Malignant HematopoiesisRyutaro Kotaki, Ryo Koyama-Nasu, Natsuko Yamakawa, et al.Seminars in Immunopathology|April 7, 2019
A new therapeutic target: the CD69-Myl9 system in immune responsesMotoko Y Kimura, Ryo Koyama-Nasu, Ryoji Yagi, et al.Cancer Science|March 25, 2025
Differentiation of Cytotoxic CD8<sup>+</sup> T Cell Subsets Under Tumor Progression: Can CD69 Be a New Therapeutic Target?Ryo Koyama-Nasu, Yangsong Wang, Hinata Miyano, et al.Nature|November 13, 2007
JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genesDavid Frescas, Daniele Guardavaccaro, Florian Bassermann, et al.Biochemical and Biophysical Research Communications|March 5, 2015
Thr160 of Axin1 is critical for the formation and function of the β-catenin destruction complexRyo Koyama-Nasu, Tomoatsu Hayashi, Yukiko Nasu-Nishimura, et al.International Immunology|November 4, 2017
Anti-tumor immunity via the superoxide-eosinophil axis induced by a lipophilic component of Mycobacterium lipomannanToshihiro Ito, Kiyoshi Hirahara, Atsushi Onodera, et al.International Immunology|June 11, 2022
The cellular and molecular basis of CD69 function in anti-tumor immunityRyo Koyama-Nasu, Yangsong Wang, Ichita Hasegawa, et al.Biochemical and Biophysical Research Communications|March 16, 2015
SOX9-mediated upregulation of LGR5 is important for glioblastoma tumorigenicityKoji Hiraoka, Tomoatsu Hayashi, Ryusuke Kaneko, et al.Molecular & Cellular Proteomics : MCP|December 17, 2015
Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (TGFBR2) as a Novel Regulator of Glioblastoma Stem Cell PropertiesYuta Narushima, Hiroko Kozuka-Hata, Ryo Koyama-Nasu, et al.Pageof 3